Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

STAT3: A key regulator in liver fibrosis Jie Zhao; Yong-Fen Qi; Yan-Rong Yu;

A social media listening study of patients¿ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study Jeffrey V. Lazarus; William Alazawi; Ron Basuroy; Laurent Castera; Dmitry Estulin; Yiannoula Koulla; Preethy Prasad; Manuel Romero-Gomez; Hirokazu Takahashi; Vincent Wai-Sun Wong; Jörn M. Schattenberg;